title: Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience.
abstract: We report the outcome of 12 children who underwent unrelated cord blood transplant (U-CBT) in a single institution between February 1997 and July 1998. The 1 year event-free survival was 67% (95% CI of 26%). Four children died with infectious complication as cause of death in three cases. Immune reconstitution was studied during first year post transplant by assaying total lymphocyte counts, B cells, NK cells and T cell subsets in the eight disease-free surviving patients. We observed a prompt recovery of CD19+ cell number which was greater than 500/microl at 9 months for all patients except the one with severe cGVHD. B cells constituted the predominant lymphocyte subset at 6 and 9 months post transplant with normal or elevated B cell numbers according to normal paediatric range. We noted normal serum immunoglobulin levels at 6 months post transplant for IgA and IgM and at 9 months for IgG. The CD3+ cell count and particularly the CD3+CD8+ T cell subset remained depressed until 12 months post transplant. Six months after unrelated CBT, seven out of eight patients had less than 100 CD3+CD8+ cells/microl. CD3+CD4+ cell recovery was less impaired with all children achieving an absolute count of CD3+CD4+ cells greater than 200/microl during the first year in a median of 5 months. The percentage of NK cells was elevated during the first 6 months after CBT but their absolute count remained within the normal range. Bone Marrow Transplantation (2000) 25, 53-57.
authors.affiliation: Service d'Hématologie Pédiatrique, Hôpital Timone Enfants, Marseille, France.
authors.forename: P
authors.initials: P
authors.lastname: Giraud
authors.forename: I
authors.initials: I
authors.lastname: Thuret
authors.forename: D
authors.initials: D
authors.lastname: Reviron
authors.forename: H
authors.initials: H
authors.lastname: Chambost
authors.forename: C
authors.initials: C
authors.lastname: Brunet
authors.forename: G
authors.initials: G
authors.lastname: Novakovitch
authors.forename: C
authors.initials: C
authors.lastname: Farnarier
authors.forename: G
authors.initials: G
authors.lastname: Michel
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005312:Fetal Blood; D016332:Fetal Tissue Transplantation; D019337:Hematologic Neoplasms / Q000276:immunology* / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D007109:Immunity; D007223:Infant; D014184:Transplantation, Homologous